AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist


Journal article


Louise Andersson, Michele Roggia, K. Wangriatisak, Maria Gil, Karine Chemin, Sandro Cosconati, P. Kozielewicz
bioRxiv, 2025

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Andersson, L., Roggia, M., Wangriatisak, K., Gil, M., Chemin, K., Cosconati, S., & Kozielewicz, P. (2025). AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist. BioRxiv.


Chicago/Turabian   Click to copy
Andersson, Louise, Michele Roggia, K. Wangriatisak, Maria Gil, Karine Chemin, Sandro Cosconati, and P. Kozielewicz. “AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist.” bioRxiv (2025).


MLA   Click to copy
Andersson, Louise, et al. “AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist.” BioRxiv, 2025.


BibTeX   Click to copy

@article{louise2025a,
  title = {AI-Driven Virtual Screening and First-in-Class Conformational Biosensor Enable the Discovery of a GPR183 Inverse Agonist},
  year = {2025},
  journal = {bioRxiv},
  author = {Andersson, Louise and Roggia, Michele and Wangriatisak, K. and Gil, Maria and Chemin, Karine and Cosconati, Sandro and Kozielewicz, P.}
}


Share


Tools
Translate to